These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 16761190

  • 1. The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.
    Tsukamoto O, Minamino T, Sanada S, Okada K, Hirata A, Fujita M, Shintani Y, Yulin L, Asano Y, Takashima S, Yamasaki S, Tomoike H, Hori M, Kitakaze M.
    Cardiovasc Drugs Ther; 2006 Apr; 20(2):93-102. PubMed ID: 16761190
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H, Minamino T, Tsukamoto O, Kim J, Okada K, Myoishi M, Wakeno M, Takashima S, Mochizuki N, Kitakaze M.
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [Abstract] [Full Text] [Related]

  • 3. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
    Nagata K, Obata K, Xu J, Ichihara S, Noda A, Kimata H, Kato T, Izawa H, Murohara T, Yokota M.
    Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
    [Abstract] [Full Text] [Related]

  • 4. Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction.
    Fraccarollo D, Galuppo P, Hildemann S, Christ M, Ertl G, Bauersachs J.
    J Am Coll Cardiol; 2003 Nov 05; 42(9):1666-73. PubMed ID: 14607457
    [Abstract] [Full Text] [Related]

  • 5. Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading.
    Martinez DV, Rocha R, Matsumura M, Oestreicher E, Ochoa-Maya M, Roubsanthisuk W, Williams GH, Adler GK.
    Hypertension; 2002 Feb 05; 39(2 Pt 2):614-8. PubMed ID: 11882618
    [Abstract] [Full Text] [Related]

  • 6. Spironolactone differently influences remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
    Simko F, Matúsková J, Lupták I, Pincíková T, Krajcírovicová K, Stvrtina S, Pomsár J, Pelouch V, Paulis L, Pechánová O.
    Physiol Res; 2007 Feb 05; 56 Suppl 2():S25-S32. PubMed ID: 17824810
    [Abstract] [Full Text] [Related]

  • 7. Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: Beneficial effects of mineralocorticoid receptor blocker.
    Ohtani T, Ohta M, Yamamoto K, Mano T, Sakata Y, Nishio M, Takeda Y, Yoshida J, Miwa T, Okamoto M, Masuyama T, Nonaka Y, Hori M.
    Am J Physiol Regul Integr Comp Physiol; 2007 Feb 05; 292(2):R946-54. PubMed ID: 17023667
    [Abstract] [Full Text] [Related]

  • 8. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
    Simko F, Luptak I, Matuskova J, Babal P, Pechanova O, Bernatova I, Hulin I.
    Ann N Y Acad Sci; 2002 Jun 05; 967():454-62. PubMed ID: 12079874
    [Abstract] [Full Text] [Related]

  • 9. Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats.
    Kataoka C, Egashira K, Inoue S, Takemoto M, Ni W, Koyanagi M, Kitamoto S, Usui M, Kaibuchi K, Shimokawa H, Takeshita A.
    Hypertension; 2002 Feb 05; 39(2):245-50. PubMed ID: 11847192
    [Abstract] [Full Text] [Related]

  • 10. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload.
    Kuster GM, Kotlyar E, Rude MK, Siwik DA, Liao R, Colucci WS, Sam F.
    Circulation; 2005 Feb 01; 111(4):420-7. PubMed ID: 15687129
    [Abstract] [Full Text] [Related]

  • 11. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
    Paulis L, Matuskova J, Adamcova M, Pelouch V, Simko J, Krajcirovicova K, Potacova A, Hulin I, Janega P, Pechanova O, Simko F.
    Acta Physiol (Oxf); 2008 Sep 01; 194(1):45-55. PubMed ID: 18419778
    [Abstract] [Full Text] [Related]

  • 12. Nitric oxide inhibition accelerates hypertension and induces perivascular inflammation in rats.
    Hsieh NK, Wang JY, Liu JC, Wang SD, Chen HI.
    Clin Exp Pharmacol Physiol; 2004 Apr 01; 31(4):212-8. PubMed ID: 15053816
    [Abstract] [Full Text] [Related]

  • 13. Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in L-NAME/SHR model.
    Zhou X, Ono H, Ono Y, Frohlich ED.
    Am J Nephrol; 2004 Apr 01; 24(2):242-9. PubMed ID: 15031627
    [Abstract] [Full Text] [Related]

  • 14. Spironolactone suppresses inflammation and prevents L-NAME-induced renal injury in rats.
    Ikeda H, Tsuruya K, Toyonaga J, Masutani K, Hayashida H, Hirakata H, Iida M.
    Kidney Int; 2009 Jan 01; 75(2):147-55. PubMed ID: 18923385
    [Abstract] [Full Text] [Related]

  • 15. Aldosterone inhibits antifibrotic factors in mouse hypertensive heart.
    Azibani F, Benard L, Schlossarek S, Merval R, Tournoux F, Fazal L, Polidano E, Launay JM, Carrier L, Chatziantoniou C, Samuel JL, Delcayre C.
    Hypertension; 2012 Jun 01; 59(6):1179-87. PubMed ID: 22547442
    [Abstract] [Full Text] [Related]

  • 16. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
    Endemann DH, Touyz RM, Iglarz M, Savoia C, Schiffrin EL.
    Hypertension; 2004 Jun 01; 43(6):1252-7. PubMed ID: 15117913
    [Abstract] [Full Text] [Related]

  • 17. Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats.
    Pechanova O, Matuskova J, Capikova D, Jendekova L, Paulis L, Simko F.
    Kidney Int; 2006 Jul 01; 70(1):170-6. PubMed ID: 16710350
    [Abstract] [Full Text] [Related]

  • 18. Effects of eplerenone on transcriptional factors and mRNA expression related to cardiac remodelling after myocardial infarction.
    Enomoto S, Yoshiyama M, Omura T, Matsumoto R, Kusuyama T, Kim S, Izumi Y, Akioka K, Iwao H, Takeuchi K, Yoshikawa J.
    Heart; 2005 Dec 01; 91(12):1595-600. PubMed ID: 15797934
    [Abstract] [Full Text] [Related]

  • 19. Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis.
    Bienvenu LA, Morgan J, Rickard AJ, Tesch GH, Cranston GA, Fletcher EK, Delbridge LM, Young MJ.
    Endocrinology; 2012 Jul 01; 153(7):3416-25. PubMed ID: 22653557
    [Abstract] [Full Text] [Related]

  • 20. Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.
    Pojoga LH, Yao TM, Opsasnick LA, Siddiqui WT, Reslan OM, Adler GK, Williams GH, Khalil RA.
    J Pharmacol Exp Ther; 2015 Oct 01; 355(1):32-47. PubMed ID: 26183312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.